Losartan: a review of its use in stroke risk reduction in patients with hypertension and left ventricular hypertrophy.
about
The occurrence of left ventricular hypertrophy in normotensive individuals in a community setting in North-East TrinidadAngiotensin-II mediates nonmuscle myosin II activation and expression and contributes to human keloid disease progressionReciprocal regulation of transcription factors and PLC isozyme gene expression in adult cardiomyocytes.
P2860
Losartan: a review of its use in stroke risk reduction in patients with hypertension and left ventricular hypertrophy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Losartan: a review of its use ...... left ventricular hypertrophy.
@ast
Losartan: a review of its use ...... left ventricular hypertrophy.
@en
type
label
Losartan: a review of its use ...... left ventricular hypertrophy.
@ast
Losartan: a review of its use ...... left ventricular hypertrophy.
@en
prefLabel
Losartan: a review of its use ...... left ventricular hypertrophy.
@ast
Losartan: a review of its use ...... left ventricular hypertrophy.
@en
P2860
P1433
P1476
Losartan: a review of its use ...... left ventricular hypertrophy.
@en
P2093
Marit D Moen
P2860
P304
P356
10.2165/00003495-200565180-00012
P577
2005-01-01T00:00:00Z
P6179
1001270216